Is a 10‑mm indeterminate lesion in the femoral head likely to be cancer?

A 10-mm Indeterminate Femoral Head Lesion: Unlikely to Be Cancer, But Requires MRI Confirmation

A 10-mm indeterminate lesion in the femoral head is most likely benign, but MRI without and with IV contrast is essential to definitively characterize the lesion and guide management. 1

Recommended Diagnostic Approach

Based on the 2025 ACR Appropriateness Criteria for suspected primary bone tumors, when radiographs show an indeterminate lesion in the femoral head, the next step is clear:

• MRI of the femoral head (with and without IV contrast) is the recommended next imaging study 1
• This provides optimal soft tissue characterization and helps differentiate benign from malignant lesions
• MRI is superior to CT for detecting and characterizing bone tumors in this scenario 1

Why This Is Likely Benign

Several factors suggest a benign etiology:

Size and Location Context:

• Small focal lesions (10 mm) in the femoral head are frequently benign entities 2, 3
• In breast cancer patients with new femoral head uptake on bone scans, only 4.8% were metastatic when no other bone metastases were present 2
• Common benign diagnoses include fibrocystic change (50%), subchondral fracture (36.7%), and osteonecrosis 2, 3

Benign Mimickers to Consider:

• Osteonecrosis: Can present as distinct focal lesions with mixed sclerosis/osteolysis, often showing characteristic MRI findings (double-line sign on T2) 4, 3
• Fibrous dysplasia: Well-defined ground-glass lesions with circular calcification 5
• Chondroblastoma: Common in the femoral head epiphysis, though typically in younger patients 6

Critical Decision Points

Patient Age Matters:

• If patient <40 years: Any aggressive symptomatic bone lesion has significant malignancy risk and warrants orthopedic oncology referral before further workup 7
• If patient ≥40 years: First evaluate for metastatic disease (history of cancer, bone scan, chest imaging) 7

Red Flags for Malignancy:

• Known bone metastases elsewhere (75% chance femoral head lesion is also metastatic) 2
• Multiple new uptake lesions on bone scan (all such patients showed metastasis) 2
• Aggressive radiographic features (cortical destruction, periosteal reaction, soft tissue mass) 1

Management Algorithm

1. Obtain MRI with and without contrast of the entire proximal femur 1

   • Evaluates anatomic extent and soft tissue involvement
   • Helps plan biopsy trajectory if needed
   • Dynamic contrast enhancement improves benign/malignant differentiation 1

2. Consider CT without contrast if:

   • Mineralized matrix needs evaluation 1
   • MRI is contraindicated
   • Surgical planning requires assessment of cortical involvement 1

3. Multidisciplinary evaluation if indeterminate or aggressive features:

   • Orthopedic oncologist
   • Musculoskeletal radiologist
   • Medical oncologist (if systemic disease suspected) 7

Common Pitfalls to Avoid

• Don't assume single uptake on bone scan = metastasis: No patient with a single femoral head uptake lesion had bone metastasis in one study 2
• Don't skip MRI for "obviously benign" radiographic appearance: Even benign-appearing lesions may require imaging if symptomatic, at fracture risk, or have indeterminate malignant potential 1
• Don't biopsy before complete staging: All suspected bone sarcomas require complete staging and oncology consultation before biopsy 7
• Don't rely solely on scintigraphy: Additional cross-sectional imaging is essential for accurate diagnosis 5

The overwhelming likelihood is that this 10-mm lesion is benign, but MRI confirmation is mandatory to avoid missing the rare malignancy and to guide appropriate management.